Robert Taylor Nelsen's Insider Trades & SAST Disclosures
Robert Taylor Nelsen's most recent trade in Lyell Immunopharma Inc was a trade of 130,000 Option (right to buy) done . Disclosure was reported to the exchange on June 14, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Robert Taylor Nelsen.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
Showing you 100 results sorted by most recent dates.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Lyell Immunopharma Inc | Robert Taylor Nelsen | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 130,000 | 130,000 | - | - | Option (right to buy) | |
| Prime Medicine Inc | Robert Taylor Nelsen | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 45,000 | 45,000 | - | - | Stock Option (right to buy) | |
| Sana Biotechnology Inc | Robert Taylor Nelsen | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 65,000 | 65,000 | - | - | Stock Option (Right to Buy) | |
| Sana Biotechnology Inc | Robert Taylor Nelsen | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 54,278 | 54,278 | - | - | Stock Option (Right to Buy) | |
| Vir Biotechnology Inc | Robert Taylor Nelsen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 16,000 | 16,000 | - | - | Stock Option (Right to Buy) | |
| Vir Biotechnology Inc | Robert Taylor Nelsen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 8,000 | 584,148 (0%) | 0% | 0 | Common Stock | |
| Prime Medicine Inc | Taylor Nelsen Robert | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 6.25 per share. | 15 Feb 2024 | 3,200,000 | 3,200,000 | - | 6.3 | 20,000,000 | Common Stock |
| Sana Biotechnology Inc | Taylor Nelsen Robert | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 5.50 per share. | 08 Feb 2024 | 727,272 | 12,446,022 | - | 5.5 | 3,999,996 | Common Stock |
| Sana Biotechnology Inc | Nelsen Robert Taylor | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 5.50 per share. | 08 Feb 2024 | 727,272 | 12,446,022 | - | 5.5 | 3,999,996 | Common Stock |
| Sana Biotechnology Inc | Taylor Robert Nelsen | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 5.50 per share. | 08 Feb 2024 | 363,637 | 10,667,387 | - | 5.5 | 2,000,004 | Common Stock |
| Lyell Immunopharma Inc | Robert Taylor Nelsen | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2023 | 65,000 | 65,000 | - | - | Option (right to buy) | |
| Prime Medicine Inc | Robert Taylor Nelsen | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 39,062 | 39,062 | - | - | Stock Option (right to buy) | |
| Sana Biotechnology Inc | Robert Taylor Nelsen | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 65,000 | 65,000 | - | - | Stock Option (Right to Buy) | |
| Vir Biotechnology Inc | Robert Taylor Nelsen | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2023 | 12,054 | 12,054 | - | - | Stock Option (Right to Buy) | |
| Vir Biotechnology Inc | Robert Taylor Nelsen | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2023 | 6,027 | 576,148 (0%) | 0% | 0 | Common Stock | |
| Sana Biotechnology Inc | Robert Taylor Nelsen | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 536 | 1,353 | - | 0 | Common Stock | |
| Prime Medicine Inc | Robert Taylor Nelsen | Director, Ten Percent Owner | 24 Oct 2022 | 16,666,667 | 0 | - | - | Series A Convertible Preferred Stock | ||
| Prime Medicine Inc | Robert Taylor Nelsen | Director, Ten Percent Owner | 24 Oct 2022 | 16,666,664 | 0 | - | - | Series A Convertible Preferred Stock | ||
| Prime Medicine Inc | Robert Taylor Nelsen | Director, Ten Percent Owner | 24 Oct 2022 | 5,728,297 | 5,728,297 | - | - | Common Stock | ||
| Prime Medicine Inc | Robert Taylor Nelsen | Director, Ten Percent Owner | 24 Oct 2022 | 5,728,297 | 5,728,297 | - | - | Common Stock | ||
| Prime Medicine Inc | Robert Taylor Nelsen | Director, Ten Percent Owner | 24 Oct 2022 | 1,141,474 | 0 | - | - | Series B Convertible Preferred Stock | ||
| Prime Medicine Inc | Robert Taylor Nelsen | Director, Ten Percent Owner | 24 Oct 2022 | 1,141,474 | 0 | - | - | Series B Convertible Preferred Stock | ||
| Prime Medicine Inc | Robert Taylor Nelsen | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 17.00 per share. | 24 Oct 2022 | 400,000 | 6,128,297 | - | 17 | 6,800,000 | Common Stock |
| Prime Medicine Inc | Robert Taylor Nelsen | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 17.00 per share. | 24 Oct 2022 | 400,000 | 6,128,297 | - | 17 | 6,800,000 | Common Stock |
| Prime Medicine Inc | Robert Taylor Nelsen | Director, Ten Percent Owner | 24 Oct 2022 | 49,999 | 0 | - | - | Series A Convertible Preferred Stock | ||
| Prime Medicine Inc | Robert Taylor Nelsen | Director, Ten Percent Owner | 24 Oct 2022 | 16,080 | 16,080 | - | - | Common Stock | ||
| Sana Biotechnology Inc | Robert Taylor Nelsen | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Oct 2022 | 321 | 817 | - | 0 | Common Stock | |
| Vir Biotechnology Inc | Robert Taylor Nelsen | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 02 Sep 2022 | 310,441 | 7,290,655 (6%) | 0% | 0 | Common Stock | |
| Vir Biotechnology Inc | Robert Taylor Nelsen | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 02 Sep 2022 | 253,997 | 7,601,096 (6%) | 0% | 0 | Common Stock | |
| Vir Biotechnology Inc | Robert Taylor Nelsen | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 02 Sep 2022 | 239,559 | 5,626,008 (5%) | 0% | 0 | Common Stock | |
| Vir Biotechnology Inc | Robert Taylor Nelsen | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 02 Sep 2022 | 196,003 | 5,865,567 (5%) | 0% | 0 | Common Stock | |
| Vir Biotechnology Inc | Robert Taylor Nelsen | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 02 Sep 2022 | 30,238 | 570,121 (0%) | 0% | 0 | Common Stock | |
| Vir Biotechnology Inc | Robert Taylor Nelsen | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 02 Sep 2022 | 24,737 | 539,883 (0%) | 0% | 0 | Common Stock | |
| Vir Biotechnology Inc | Robert Taylor Nelsen | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 02 Sep 2022 | 1,850 | 33,893 (0%) | 0% | 0 | Common Stock | |
| Vir Biotechnology Inc | Robert Taylor Nelsen | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 02 Sep 2022 | 1,508 | 32,043 (0%) | 0% | 0 | Common Stock | |
| Vir Biotechnology Inc | Robert Taylor Nelsen | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 30 Aug 2022 | 282,219 | 8,137,312 (7%) | 0% | 0 | Common Stock | |
| Vir Biotechnology Inc | Robert Taylor Nelsen | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 30 Aug 2022 | 282,219 | 7,855,093 (7%) | 0% | 0 | Common Stock | |
| Vir Biotechnology Inc | Robert Taylor Nelsen | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 30 Aug 2022 | 217,781 | 6,061,570 (5%) | 0% | 0 | Common Stock | |
| Vir Biotechnology Inc | Robert Taylor Nelsen | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 30 Aug 2022 | 217,781 | 6,279,351 (5%) | 0% | 0 | Common Stock | |
| Vir Biotechnology Inc | Robert Taylor Nelsen | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 30 Aug 2022 | 27,489 | 515,146 (0%) | 0% | 0 | Common Stock | |
| Vir Biotechnology Inc | Robert Taylor Nelsen | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 30 Aug 2022 | 27,489 | 487,657 (0%) | 0% | 0 | Common Stock | |
| Vir Biotechnology Inc | Robert Taylor Nelsen | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 30 Aug 2022 | 1,684 | 30,535 (0%) | 0% | 0 | Common Stock | |
| Vir Biotechnology Inc | Robert Taylor Nelsen | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 30 Aug 2022 | 1,684 | 28,851 (0%) | 0% | 0 | Common Stock | |
| Vir Biotechnology Inc | Robert Taylor Nelsen | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 24 Aug 2022 | 282,219 | 8,701,750 (7%) | 0% | 0 | Common Stock | |
| Vir Biotechnology Inc | Robert Taylor Nelsen | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 24 Aug 2022 | 282,219 | 8,419,531 (7%) | 0% | 0 | Common Stock | |
| Vir Biotechnology Inc | Robert Taylor Nelsen | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 24 Aug 2022 | 217,781 | 6,497,132 (5%) | 0% | 0 | Common Stock | |
| Vir Biotechnology Inc | Robert Taylor Nelsen | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 24 Aug 2022 | 217,781 | 6,714,913 (6%) | 0% | 0 | Common Stock | |
| Vir Biotechnology Inc | Robert Taylor Nelsen | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 24 Aug 2022 | 27,489 | 460,168 (0%) | 0% | 0 | Common Stock | |
| Vir Biotechnology Inc | Robert Taylor Nelsen | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 24 Aug 2022 | 27,489 | 432,679 (0%) | 0% | 0 | Common Stock | |
| Vir Biotechnology Inc | Robert Taylor Nelsen | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 24 Aug 2022 | 1,684 | 27,167 (0%) | 0% | 0 | Common Stock | |
| Vir Biotechnology Inc | Robert Taylor Nelsen | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 24 Aug 2022 | 1,684 | 25,483 (0%) | 0% | 0 | Common Stock | |
| Vir Biotechnology Inc | Robert Taylor Nelsen | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 18 Aug 2022 | 282,219 | 8,983,969 (8%) | 0% | 0 | Common Stock | |
| Vir Biotechnology Inc | Robert Taylor Nelsen | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 18 Aug 2022 | 217,781 | 6,932,694 (6%) | 0% | 0 | Common Stock | |
| Vir Biotechnology Inc | Robert Taylor Nelsen | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 18 Aug 2022 | 27,489 | 405,190 (0%) | 0% | 0 | Common Stock | |
| Vir Biotechnology Inc | Robert Taylor Nelsen | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 18 Aug 2022 | 1,684 | 23,799 (0%) | 0% | 0 | Common Stock | |
| Vir Biotechnology Inc | Robert Taylor Nelsen | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 12 Aug 2022 | 282,219 | 9,266,188 (8%) | 0% | 0 | Common Stock | |
| Vir Biotechnology Inc | Robert Taylor Nelsen | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 12 Aug 2022 | 282,219 | 9,548,407 (8%) | 0% | 0 | Common Stock | |
| Vir Biotechnology Inc | Robert Taylor Nelsen | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 12 Aug 2022 | 282,219 | 9,830,626 (8%) | 0% | 0 | Common Stock | |
| Vir Biotechnology Inc | Robert Taylor Nelsen | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 12 Aug 2022 | 217,781 | 7,586,037 (6%) | 0% | 0 | Common Stock | |
| Vir Biotechnology Inc | Robert Taylor Nelsen | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 12 Aug 2022 | 217,781 | 7,150,475 (6%) | 0% | 0 | Common Stock | |
| Vir Biotechnology Inc | Robert Taylor Nelsen | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 12 Aug 2022 | 217,781 | 7,368,256 (6%) | 0% | 0 | Common Stock | |
| Vir Biotechnology Inc | Robert Taylor Nelsen | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 12 Aug 2022 | 27,489 | 377,701 (0%) | 0% | 0 | Common Stock | |
| Vir Biotechnology Inc | Robert Taylor Nelsen | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 12 Aug 2022 | 27,489 | 350,212 (0%) | 0% | 0 | Common Stock | |
| Vir Biotechnology Inc | Robert Taylor Nelsen | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 12 Aug 2022 | 27,489 | 322,723 (0%) | 0% | 0 | Common Stock | |
| Vir Biotechnology Inc | Robert Taylor Nelsen | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 12 Aug 2022 | 1,684 | 22,115 (0%) | 0% | 0 | Common Stock | |
| Vir Biotechnology Inc | Robert Taylor Nelsen | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 12 Aug 2022 | 1,684 | 20,431 (0%) | 0% | 0 | Common Stock | |
| Vir Biotechnology Inc | Robert Taylor Nelsen | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 12 Aug 2022 | 1,684 | 18,747 (0%) | 0% | 0 | Common Stock | |
| Sana Biotechnology Inc | Robert Taylor Nelsen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jul 2022 | 266 | 496 | - | 0 | Common Stock | |
| Lyell Immunopharma Inc | Robert Taylor Nelsen | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 65,000 | 65,000 | - | - | Option (right to buy) | |
| Sana Biotechnology Inc | Robert Taylor Nelsen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2022 | 65,000 | 65,000 | - | - | Stock Option (Right to Buy) | |
| Vir Biotechnology Inc | Robert Taylor Nelsen | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 02 Jun 2022 | 282,219 | 10,395,064 (9%) | 0% | 0 | Common Stock | |
| Vir Biotechnology Inc | Robert Taylor Nelsen | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 02 Jun 2022 | 217,781 | 8,021,599 (7%) | 0% | 0 | Common Stock | |
| Vir Biotechnology Inc | Robert Taylor Nelsen | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 02 Jun 2022 | 29,173 | 283,124 (0%) | 0% | 0 | Common Stock | |
| Vir Biotechnology Inc | Robert Taylor Nelsen | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2022 | 12,810 | 12,810 | - | - | Stock Option (Right to Buy) | |
| Vir Biotechnology Inc | Robert Taylor Nelsen | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2022 | 6,405 | 253,951 (0%) | 0% | 0 | Common Stock | |
| Sana Biotechnology Inc | Robert Taylor Nelsen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Apr 2022 | 230 | 230 | - | 0 | Common Stock | |
| Vir Biotechnology Inc | Robert Taylor Nelsen | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 20 Dec 2021 | 987,767 | 10,677,283 (9%) | 0% | 0 | Common Stock | |
| Vir Biotechnology Inc | Robert Taylor Nelsen | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 20 Dec 2021 | 762,233 | 8,239,380 (7%) | 0% | 0 | Common Stock | |
| Vir Biotechnology Inc | Robert Taylor Nelsen | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 20 Dec 2021 | 102,041 | 244,172 (0%) | 0% | 0 | Common Stock | |
| Vir Biotechnology Inc | Robert Taylor Nelsen | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 29 Nov 2021 | 282,219 | 11,665,050 (10%) | 0% | 0 | Common Stock | |
| Vir Biotechnology Inc | Robert Taylor Nelsen | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 29 Nov 2021 | 217,781 | 9,001,613 (8%) | 0% | 0 | Common Stock | |
| Vir Biotechnology Inc | Robert Taylor Nelsen | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 29 Nov 2021 | 29,153 | 142,131 (0%) | 0% | 0 | Common Stock | |
| Vir Biotechnology Inc | Robert Taylor Nelsen | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 22 Nov 2021 | 282,219 | 11,947,269 (10%) | 0% | 0 | Common Stock | |
| Vir Biotechnology Inc | Robert Taylor Nelsen | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 22 Nov 2021 | 217,781 | 9,219,394 (8%) | 0% | 0 | Common Stock | |
| Vir Biotechnology Inc | Robert Taylor Nelsen | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 22 Nov 2021 | 29,153 | 112,978 (0%) | 0% | 0 | Common Stock | |
| Vir Biotechnology Inc | Robert Taylor Nelsen | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 01 Jul 2021 | 2,257,752 | 12,229,488 (11%) | 2% | 0 | Common Stock | |
| Vir Biotechnology Inc | Robert Taylor Nelsen | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 01 Jul 2021 | 1,742,248 | 9,437,175 (8%) | 1% | 0 | Common Stock | |
| Vir Biotechnology Inc | Robert Taylor Nelsen | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 01 Jul 2021 | 47,897 | 83,825 (0%) | 0% | 0 | Common Stock | |
| Vir Biotechnology Inc | Robert Taylor Nelsen | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 22 Jun 2021 | 564,438 | 14,487,240 (13%) | 0% | 0 | Common Stock | |
| Vir Biotechnology Inc | Robert Taylor Nelsen | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 22 Jun 2021 | 435,562 | 11,179,423 (10%) | 0% | 0 | Common Stock | |
| Vir Biotechnology Inc | Robert Taylor Nelsen | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 22 Jun 2021 | 11,974 | 35,928 (0%) | 0% | 0 | Common Stock | |
| Denali Therapeutics Inc | Robert Taylor Nelsen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2021 | 6,222 | 6,222 | - | - | Stock Option (right to buy) | |
| Denali Therapeutics Inc | Robert Taylor Nelsen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2021 | 2,074 | 12,432 (0%) | 0% | 0 | Common Stock | |
| Vir Biotechnology Inc | Robert Taylor Nelsen | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2021 | 6,748 | 6,748 | - | - | Stock Option (Right to Buy) | |
| Vir Biotechnology Inc | Robert Taylor Nelsen | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2021 | 3,374 | 27,328 (0%) | 0% | 0 | Common Stock | |
| Karuna Therapeutics Inc | Robert Taylor Nelsen | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 13 Apr 2021 | 75,000 | 1,456,437 (5%) | 0% | 0 | Common Stock | |
| Karuna Therapeutics Inc | Robert Taylor Nelsen | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 13 Apr 2021 | 75,000 | 1,456,435 (5%) | 0% | 0 | Common Stock | |
| Karuna Therapeutics Inc | Robert Taylor Nelsen | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 13 Apr 2021 | 1,756 | 5,269 (0%) | 0% | 0 | Common Stock | |
| Vir Biotechnology Inc | Robert Taylor Nelsen | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 07 Apr 2021 | 282,219 | 15,051,678 (13%) | 0% | 0 | Common Stock | |
| Vir Biotechnology Inc | Robert Taylor Nelsen | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 07 Apr 2021 | 282,219 | 15,333,897 (13%) | 0% | 0 | Common Stock | |
| Vir Biotechnology Inc | Robert Taylor Nelsen | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 07 Apr 2021 | 217,781 | 11,832,766 (10%) | 0% | 0 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges